Cargando…

The Australian living guidelines for the clinical care of people with COVID-19: What worked, what didn’t and why, a mixed methods process evaluation

INTRODUCTION: The Australian National COVID-19 Clinical Evidence Taskforce is producing living, evidence-based, national guidelines for treatment of people with COVID-19 which are updated each week. To continually improve the process and outputs of the Taskforce, and inform future living guideline d...

Descripción completa

Detalles Bibliográficos
Autores principales: Turner, Tari, Elliott, Julian, Tendal, Britta, Vogel, Joshua P., Norris, Sarah, Tate, Rhiannon, Green, Sally
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8741039/
https://www.ncbi.nlm.nih.gov/pubmed/34995312
http://dx.doi.org/10.1371/journal.pone.0261479
_version_ 1784629416640380928
author Turner, Tari
Elliott, Julian
Tendal, Britta
Vogel, Joshua P.
Norris, Sarah
Tate, Rhiannon
Green, Sally
author_facet Turner, Tari
Elliott, Julian
Tendal, Britta
Vogel, Joshua P.
Norris, Sarah
Tate, Rhiannon
Green, Sally
author_sort Turner, Tari
collection PubMed
description INTRODUCTION: The Australian National COVID-19 Clinical Evidence Taskforce is producing living, evidence-based, national guidelines for treatment of people with COVID-19 which are updated each week. To continually improve the process and outputs of the Taskforce, and inform future living guideline development, we undertook a concurrent process evaluation examining Taskforce activities and experience of team members and stakeholders during the first 5 months of the project. METHODS: The mixed-methods process evaluation consisted of activity and progress audits, an online survey of all Taskforce participants; and semi-structured interviews with key contributors. Data were collected through five, prospective 4-weekly timepoints (beginning first week of May 2020) and three, fortnightly retrospective timepoints (March 23, April 6 and 20). We collected and analysed quantitative and qualitative data. RESULTS: An updated version of the guidelines was successfully published every week during the process evaluation. The Taskforce formed in March 2020, with a nominal start date of March 23. The first version of the guideline was published two weeks later and included 10 recommendations. By August 24, in the final round of the process evaluation, the team of 11 staff, working with seven guideline panels and over 200 health decision-makers, had developed 66 recommendations addressing 58 topics. The Taskforce website had received over 200,000 page views. Satisfaction with the work of the Taskforce remained very high (>90% extremely or somewhat satisfied) throughout. Several key strengths, challenges and methods questions for the work of the Taskforce were identified. CONCLUSIONS: In just over 5 months of activity, the National COVID-19 Clinical Evidence Taskforce published 20 weekly updates to the evidence-based national treatment guidelines for COVID-19. This process evaluation identified several factors that enabled this achievement (e.g. an extant skill base in evidence review and convening), along with challenges that needed to be overcome (e.g. managing workloads, structure and governance) and methods questions (pace of updating, and thresholds for inclusion of evidence) which may be useful considerations for other living guidelines projects. An impact evaluation is also being conducted separately to examine awareness, acceptance and use of the guidelines.
format Online
Article
Text
id pubmed-8741039
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-87410392022-01-08 The Australian living guidelines for the clinical care of people with COVID-19: What worked, what didn’t and why, a mixed methods process evaluation Turner, Tari Elliott, Julian Tendal, Britta Vogel, Joshua P. Norris, Sarah Tate, Rhiannon Green, Sally PLoS One Research Article INTRODUCTION: The Australian National COVID-19 Clinical Evidence Taskforce is producing living, evidence-based, national guidelines for treatment of people with COVID-19 which are updated each week. To continually improve the process and outputs of the Taskforce, and inform future living guideline development, we undertook a concurrent process evaluation examining Taskforce activities and experience of team members and stakeholders during the first 5 months of the project. METHODS: The mixed-methods process evaluation consisted of activity and progress audits, an online survey of all Taskforce participants; and semi-structured interviews with key contributors. Data were collected through five, prospective 4-weekly timepoints (beginning first week of May 2020) and three, fortnightly retrospective timepoints (March 23, April 6 and 20). We collected and analysed quantitative and qualitative data. RESULTS: An updated version of the guidelines was successfully published every week during the process evaluation. The Taskforce formed in March 2020, with a nominal start date of March 23. The first version of the guideline was published two weeks later and included 10 recommendations. By August 24, in the final round of the process evaluation, the team of 11 staff, working with seven guideline panels and over 200 health decision-makers, had developed 66 recommendations addressing 58 topics. The Taskforce website had received over 200,000 page views. Satisfaction with the work of the Taskforce remained very high (>90% extremely or somewhat satisfied) throughout. Several key strengths, challenges and methods questions for the work of the Taskforce were identified. CONCLUSIONS: In just over 5 months of activity, the National COVID-19 Clinical Evidence Taskforce published 20 weekly updates to the evidence-based national treatment guidelines for COVID-19. This process evaluation identified several factors that enabled this achievement (e.g. an extant skill base in evidence review and convening), along with challenges that needed to be overcome (e.g. managing workloads, structure and governance) and methods questions (pace of updating, and thresholds for inclusion of evidence) which may be useful considerations for other living guidelines projects. An impact evaluation is also being conducted separately to examine awareness, acceptance and use of the guidelines. Public Library of Science 2022-01-07 /pmc/articles/PMC8741039/ /pubmed/34995312 http://dx.doi.org/10.1371/journal.pone.0261479 Text en © 2022 Turner et al https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Turner, Tari
Elliott, Julian
Tendal, Britta
Vogel, Joshua P.
Norris, Sarah
Tate, Rhiannon
Green, Sally
The Australian living guidelines for the clinical care of people with COVID-19: What worked, what didn’t and why, a mixed methods process evaluation
title The Australian living guidelines for the clinical care of people with COVID-19: What worked, what didn’t and why, a mixed methods process evaluation
title_full The Australian living guidelines for the clinical care of people with COVID-19: What worked, what didn’t and why, a mixed methods process evaluation
title_fullStr The Australian living guidelines for the clinical care of people with COVID-19: What worked, what didn’t and why, a mixed methods process evaluation
title_full_unstemmed The Australian living guidelines for the clinical care of people with COVID-19: What worked, what didn’t and why, a mixed methods process evaluation
title_short The Australian living guidelines for the clinical care of people with COVID-19: What worked, what didn’t and why, a mixed methods process evaluation
title_sort australian living guidelines for the clinical care of people with covid-19: what worked, what didn’t and why, a mixed methods process evaluation
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8741039/
https://www.ncbi.nlm.nih.gov/pubmed/34995312
http://dx.doi.org/10.1371/journal.pone.0261479
work_keys_str_mv AT turnertari theaustralianlivingguidelinesfortheclinicalcareofpeoplewithcovid19whatworkedwhatdidntandwhyamixedmethodsprocessevaluation
AT elliottjulian theaustralianlivingguidelinesfortheclinicalcareofpeoplewithcovid19whatworkedwhatdidntandwhyamixedmethodsprocessevaluation
AT tendalbritta theaustralianlivingguidelinesfortheclinicalcareofpeoplewithcovid19whatworkedwhatdidntandwhyamixedmethodsprocessevaluation
AT vogeljoshuap theaustralianlivingguidelinesfortheclinicalcareofpeoplewithcovid19whatworkedwhatdidntandwhyamixedmethodsprocessevaluation
AT norrissarah theaustralianlivingguidelinesfortheclinicalcareofpeoplewithcovid19whatworkedwhatdidntandwhyamixedmethodsprocessevaluation
AT taterhiannon theaustralianlivingguidelinesfortheclinicalcareofpeoplewithcovid19whatworkedwhatdidntandwhyamixedmethodsprocessevaluation
AT greensally theaustralianlivingguidelinesfortheclinicalcareofpeoplewithcovid19whatworkedwhatdidntandwhyamixedmethodsprocessevaluation
AT theaustralianlivingguidelinesfortheclinicalcareofpeoplewithcovid19whatworkedwhatdidntandwhyamixedmethodsprocessevaluation
AT turnertari australianlivingguidelinesfortheclinicalcareofpeoplewithcovid19whatworkedwhatdidntandwhyamixedmethodsprocessevaluation
AT elliottjulian australianlivingguidelinesfortheclinicalcareofpeoplewithcovid19whatworkedwhatdidntandwhyamixedmethodsprocessevaluation
AT tendalbritta australianlivingguidelinesfortheclinicalcareofpeoplewithcovid19whatworkedwhatdidntandwhyamixedmethodsprocessevaluation
AT vogeljoshuap australianlivingguidelinesfortheclinicalcareofpeoplewithcovid19whatworkedwhatdidntandwhyamixedmethodsprocessevaluation
AT norrissarah australianlivingguidelinesfortheclinicalcareofpeoplewithcovid19whatworkedwhatdidntandwhyamixedmethodsprocessevaluation
AT taterhiannon australianlivingguidelinesfortheclinicalcareofpeoplewithcovid19whatworkedwhatdidntandwhyamixedmethodsprocessevaluation
AT greensally australianlivingguidelinesfortheclinicalcareofpeoplewithcovid19whatworkedwhatdidntandwhyamixedmethodsprocessevaluation
AT australianlivingguidelinesfortheclinicalcareofpeoplewithcovid19whatworkedwhatdidntandwhyamixedmethodsprocessevaluation